Alpine Immune Sciences, Inc.
USD64.97
+0.01 (+0.02%)
CEO
Mitchell H. Gold
IPO Date
2015-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$64.98
Prev. Close
$64.96
Day Low
$64.97
Day High
$65.00
52W Low
$8.33
52W High
$65.00
Market Cap
$4.46B
Volume
4.29M
| -4.3 |
| 31 Dec 2021 | FY | 97.4% | -214.7% | -41.6% | -19.7% | 0.16 | 2.75 | -7.0 |
| 31 Dec 2020 | FY | -191.2% | -299.3% | -44.9% | -19.4% | 0.36 | 2.60 | -9.4 |
| 31 Dec 2019 | FY | -1960.2% | -2444.5% | -144.3% | -78.6% | 0.55 | 4.87 | -1.7 |
| 31 Dec 2018 | FY | -4009.2% | -5175.5% | -81.8% | -66.5% | 0.09 | 6.59 | -1.4 |
| 31 Dec 2017 | FY | -513.9% | -449.6% | -9.9% | -9.1% | 0.06 | 43.56 | -9.3 |
| 31 Dec 2016 | FY | 95.2% | -1066.5% | -56.8% | -50.8% | 0.00 | 9.49 | -1.1 |
| 31 Dec 2015 | FY | 86.6% | -4637.8% | -27.3% | -26.0% | 0.00 | 19.84 | -3.2 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 95.5% | -52.7% | 0.00 | 11.78 | -9.1 |
| 48.2 |
| 30 Sept 2023 | Q3 | 98.5% | -116.7% | -7.3% | -4.9% | 0.06 | 3.81 | -12.0 |
| 30 Jun 2023 | Q2 | 98.3% | -153.1% | -7.8% | -5.2% | 0.06 | 3.88 | -9.4 |
| 31 Mar 2023 | Q1 | 98.5% | -117.3% | -6.5% | -4.2% | 0.08 | 3.48 | -8.3 |
| 31 Dec 2022 | Q4 | 94.8% | -679.5% | -10.5% | -6.6% | 0.08 | 4.16 | -4.5 |
| 30 Sept 2022 | Q3 | 98.2% | -152.0% | -7.0% | -4.4% | 0.09 | 3.70 | -4.5 |
| 30 Jun 2022 | Q2 | 97.1% | -342.0% | -18.2% | -8.4% | 0.17 | 2.75 | -3.6 |
| 31 Mar 2022 | Q1 | 98.9% | -55.2% | -6.5% | -3.2% | 0.16 | 2.58 | -9.0 |
| 31 Dec 2021 | Q4 | 97.0% | -334.8% | -12.5% | -5.9% | 0.16 | 2.75 | -6.7 |